Abstract:Purpose: Dihydromyricetin (DHM) is the major bioactive constituent of rattan tea. Our aim was to investigate the possible mechanism and the effect of DHM in counteracting hypobaric hypoxia (HH)-induced exercise intolerance. Methods: Male Sprague-Dawley rats were pretreated with three doses of DHM (50, 75, and 100 mg · kg(-1)) for 7 d and subjected to simulated high-altitude conditions (5000 m with 10.9% oxygen). Physical performance was assessed with the run-to-fatigue model. Mitochondrial morphology in the gastrocnemius muscle was observed by transmission electron microscopy. Protein expression was detected by western blotting. The activity of mitochondrial electron transport chain was analyzed by enzyme-linked immunosorbent assay. Results: DHM administration prolonged the run-to-fatigue time in a dose-dependent manner compared with the control (22.9 ± 2.2, 46.1 ± 4.4, 61.3 ± 3.1 vs 18.4 ± 1.7 min, which represented 50, 75, 100 mg · kg(-1), and the control groups, respectively). DHM also reduced serum blood urea nitrogen, lactate dehydrogenase, and creatine kinase activity levels. HH-induced mitochondrial injuries, including morphological changes, reduction in mitochondrial density and mitochondrial DNA content, and decrease in respiratory chain complex (I, II, IV, and V) activities were effectively attenuated by DHM. Protein expression of mitochondrial biogenesis markers, including peroxisome proliferator-activated receptor-γ coactivator 1α, sirtuin 1, nuclear respiratory factor 1, mitochondrial transcription factor A, AMP-activated protein kinase, and AMP-activated protein kinase phosphorylation, was significantly downregulated in HH, whereas DHM pretreatment significantly restored expression levels. DHM also modulated mitochondrial dynamics of fusion and fission by increasing mitofusins 1 and 2, while decreasing fission-related, dynamin-related protein 1 and mitochondrial fission 1. Conclusions: DHM improves physical performance under simulated high-altitude conditions via protecting mitochondrial biogenesis and modulating mitochondrial dynamics in skeletal muscle cells.

Dihydromyricetin alters myosin heavy chain expression via AMPK signaling pathway in porcine myotubes

Effect of dietary dihydromyricetin supplementation on lipid metabolism, antioxidant capacity and skeletal muscle fiber type transformation in mice

Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway

Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1α-Sirt3 signaling pathway

Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity

Procyanidin B2 Induces Porcine Skeletal Slow-Twitch Myofiber Gene Expression by AMP-activated Protein Kinase Signaling Pathway.

Dihydromyricetin Improves Meat Quality and Promotes Skeletal Muscle Fiber Type Transformations Via AMPK Signaling in Growing-Finishing Pigs

Resveratrol regulates muscle fiber type gene expression through AMPK signaling pathway and miR-22-3p in porcine myotubes

DHA/EPA Improves GLUT4 Translocation, Glycogen Synthesis and Aerobic Glycolysis in Skeletal Muscle of Db/db Mice

Ampelopsin Attenuates the Atrophy of Skeletal Muscle from D -Gal-induced Aging Rats Through Activating AMPK/SIRT1/PGC-1α Signaling Cascade

Protective Effect of Dihydromyricetin Against Exercise-Induced Muscle Damage and Its Mechanism

Dihydromyricetin promotes GLP-1 secretion to improve insulin resistance via "gut microbiota-CDCA"

Anti-hyperglycemic Effects of Dihydromyricetin in Streptozotocin-Induced Diabetic Rats

DMH1 Increases Glucose Metabolism Through Activating Akt in L6 Rat Skeletal Muscle Cells.

Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

Dihydromyricetin improves physical performance under simulated high altitude

Dihydromyricetin resists inflammation-induced muscle atrophy via ryanodine receptor-CaMKK-AMPK signal pathway

Dihydromyricetin Enhances Exercise-Induced GLP-1 Elevation through Stimulating cAMP and Inhibiting DPP-4

Dihydromyricetin prevents obesity-induced slow-twitch-fiber reduction partially via FLCN/FNIP1/AMPK pathway

Ellagic Acid Alters Muscle Fiber-Type Composition and Promotes Mitochondrial Biogenesis Through the AMPK Signaling Pathway in Healthy Pigs